Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

CD81 is a novel immunotherapeutic target for B cell lymphoma.

Vences-Catalán F, Kuo CC, Rajapaksa R, Duault C, Andor N, Czerwinski DK, Levy R, Levy S.

J Exp Med. 2019 Jul 1;216(7):1497-1508. doi: 10.1084/jem.20190186. Epub 2019 May 23.

PMID:
31123084
2.

EspH Suppresses Erk by Spatial Segregation from CD81 Tetraspanin Microdomains.

Ramachandran RP, Vences-Catalán F, Wiseman D, Zlotkin-Rivkin E, Shteyer E, Melamed-Book N, Rosenshine I, Levy S, Aroeti B.

Infect Immun. 2018 Sep 21;86(10). pii: e00303-18. doi: 10.1128/IAI.00303-18. Print 2018 Oct.

3.

Immune Targeting of Tetraspanins Involved in Cell Invasion and Metastasis.

Vences-Catalán F, Levy S.

Front Immunol. 2018 Jun 12;9:1277. doi: 10.3389/fimmu.2018.01277. eCollection 2018. Review.

4.

Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression.

Hebb JPO, Mosley AR, Vences-Catalán F, Rajasekaran N, Rosén A, Ellmark P, Felsher DW.

Cancer Immunol Immunother. 2018 Jan;67(1):47-60. doi: 10.1007/s00262-017-2059-y. Epub 2017 Sep 13.

PMID:
28905118
5.

CD81 association with SAMHD1 enhances HIV-1 reverse transcription by increasing dNTP levels.

Rocha-Perugini V, Suárez H, Álvarez S, López-Martín S, Lenzi GM, Vences-Catalán F, Levy S, Kim B, Muñoz-Fernández MA, Sánchez-Madrid F, Yáñez-Mó M.

Nat Microbiol. 2017 Nov;2(11):1513-1522. doi: 10.1038/s41564-017-0019-0. Epub 2017 Sep 4.

6.

Tspan33 is Expressed in Transitional and Memory B Cells, but is not Responsible for High ADAM10 Expression.

Pérez-Martínez CA, Maravillas-Montero JL, Meza-Herrera I, Vences-Catalán F, Zlotnik A, Santos-Argumedo L.

Scand J Immunol. 2017 Jul;86(1):23-30. doi: 10.1111/sji.12559.

7.

CD81 as a tumor target.

Vences-Catalán F, Duault C, Kuo CC, Rajapaksa R, Levy R, Levy S.

Biochem Soc Trans. 2017 Apr 15;45(2):531-535. doi: 10.1042/BST20160478. Review.

PMID:
28408492
8.

Tetraspanin CD81, a modulator of immune suppression in cancer and metastasis.

Vences-Catalán F, Rajapaksa R, Srivastava MK, Marabelle A, Kuo CC, Levy R, Levy S.

Oncoimmunology. 2015 Dec 18;5(5):e1120399. doi: 10.1080/2162402X.2015.1120399. eCollection 2016 May.

9.

Tetraspanin CD81 promotes tumor growth and metastasis by modulating the functions of T regulatory and myeloid-derived suppressor cells.

Vences-Catalán F, Rajapaksa R, Srivastava MK, Marabelle A, Kuo CC, Levy R, Levy S.

Cancer Res. 2015 Nov 1;75(21):4517-26. doi: 10.1158/0008-5472.CAN-15-1021. Epub 2015 Sep 1.

10.

Role of an arginine-lysine rich motif in maturation and trafficking of CD19.

Vences-Catalán F, Kuo CC, Levy S.

Biochem Biophys Res Commun. 2015 Sep 25;465(3):319-23. doi: 10.1016/j.bbrc.2015.06.129. Epub 2015 Jun 23.

PMID:
26111452
11.

A mutation in the human tetraspanin CD81 gene is expressed as a truncated protein but does not enable CD19 maturation and cell surface expression.

Vences-Catalán F, Kuo CC, Sagi Y, Chen H, Kela-Madar N, van Zelm MC, van Dongen JJ, Levy S.

J Clin Immunol. 2015 Apr;35(3):254-63. doi: 10.1007/s10875-015-0148-2. Epub 2015 Mar 6.

PMID:
25739915
12.

Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein.

Al Olaby RR, Cocquerel L, Zemla A, Saas L, Dubuisson J, Vielmetter J, Marcotrigiano J, Khan AG, Vences Catalan F, Perryman AL, Freundlich JS, Forli S, Levy S, Balhorn R, Azzazy HM.

PLoS One. 2014 Oct 30;9(10):e111333. doi: 10.1371/journal.pone.0111333. eCollection 2014.

13.

TSPAN33 is a novel marker of activated and malignant B cells.

Luu VP, Hevezi P, Vences-Catalan F, Maravillas-Montero JL, White CA, Casali P, Llorente L, Jakez-Ocampo J, Lima G, Vilches-Cisneros N, Flores-Gutiérrez JP, Santos-Argumedo L, Zlotnik A.

Clin Immunol. 2013 Dec;149(3):388-99. doi: 10.1016/j.clim.2013.08.005. Epub 2013 Aug 15.

14.

The CD19/CD81 complex physically interacts with CD38 but is not required to induce proliferation in mouse B lymphocytes.

Vences-Catalán F, Rajapaksa R, Levy S, Santos-Argumedo L.

Immunology. 2012 Sep;137(1):48-55. doi: 10.1111/j.1365-2567.2012.03602.x.

15.

Consequences of two naturally occurring missense mutations in the structure and function of Bruton agammaglobulinemia tyrosine kinase.

Vargas-Hernández A, López-Herrera G, Maravillas-Montero JL, Vences-Catalán F, Mogica-Martínez D, Rojo-Domínguez A, Espinosa-Rosales FJ, Santos-Argumedo L.

IUBMB Life. 2012 Apr;64(4):346-53. doi: 10.1002/iub.1009. Epub 2012 Feb 29.

16.

CD38 through the life of a murine B lymphocyte.

Vences-Catalán F, Santos-Argumedo L.

IUBMB Life. 2011 Oct;63(10):840-6. doi: 10.1002/iub.549. Epub 2011 Sep 7. Review.

Supplemental Content

Loading ...
Support Center